Licence extension for Januvia

Januvia (sitagliptin) is now licensed for first-line treatment of type II diabetes when metformin is contraindicated or not tolerated. The recommended dose is 100mg once daily.

View Januvia drug record

Further information: Merck

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

More from intelog

Drug shortages - live tracker

Drug shortages - live tracker

Added: ranitidine.
Use our constantly updated...

intelog Learning's Espresso CPD helps GPs to top up credits for appraisal

intelog Learning's Espresso CPD helps GPs to top up credits for appraisal

Bite-size Espresso learning can help you top up your...

Monitor high-risk statin patients for osteoporosis, say researchers

Monitor high-risk statin patients for osteoporosis, say researchers

Patients taking high-dose statins who are at increased...

Oral Iron Supplements for Iron-Deficiency States

Oral Iron Supplements for Iron-Deficiency States

Formulations, strengths, doses and costs of iron supplements.